ganciclovir

The drug is intended for adults and adolescents (from 12 years of age) for the treatment of cytomegalovirus (CMV) infection in patients with immunodeficiencies, as well as for its prevention in patients with drug-induced immunosuppression (e.g., after organ transplantation or chemotherapy). In infants from birth, the drug is prescribed for universal prophylaxis of CMV infection in cases of drug-induced immunosuppression.

Form: powder for solution for infusion

ATC: J05AB06

Manufacturer: F. Hoffmann-La Roche Ltd (secondary packaging, quality control testing)

The drug is used to treat cytomegalovirus (CMV) infection in immunocompromised patients, as well as to prevent this infection in patients receiving immunosuppressive therapy (e.g., after organ transplantation or chemotherapy).

Form: powder for solution for infusion

ATC: J05AB06

Manufacturer: Farmex Group LLC

The drug is intended for the treatment of cytomegalovirus infection in immunocompromised patients, as well as for the prevention of this infection in patients undergoing drug-induced immunosuppression (e.g., after organ transplantation or chemotherapy).

Form: powder for solution for infusion

ATC: J05AB06

Manufacturer: Mefar Ilac San. A.S.

The drug is used for the treatment of acute superficial keratitis caused by the herpes simplex virus.

Form: gel, ophthalmic

ATC: S01AD09

Manufacturer: Farmila - Thea Farmaceutici S.p.A.